Gareb, Bahez <br/><br/>
Development of a zero-order sustained-release tablet containing mesalazine and budesonide intended to treat the distal gastrointestinal tract in inflammatory bowel disease.  [electronic resource] 

 -  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V  Jun 2016 
 - 32-42 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-3441 
<br/><br/><label>Standard No.: </label>10.1016/j.ejpb.2016.03.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Budesonide--therapeutic use<br/>Delayed-Action Preparations<br/>Humans<br/>Inflammatory Bowel Diseases--drug therapy<br/>Mesalamine--therapeutic use<br/>Tablets